Thoracic Oncology Laboratory »  Publications

Publications

View by Year:
 
Raz DJ, Zell JA, Karnezis AN, Odisho A, Ignatius Ou SH, Anton-Culver H, Jablons DM
Misclassification of bronchioloalveolar carcinoma with cytologic diagnosis of lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, Nov-2006;1(9):943-8.
Raz DJ, Odisho AY, Franc BL, Jablons DM
Tumor fluoro-2-deoxy-D-glucose avidity on positron emission tomographic scan predicts mortality in patients with early-stage pure and mixed bronchioloalveolar carcinoma.
The Journal of thoracic and cardiovascular surgery, Nov-2006;132(5):1189-95.
To MD, Perez-Losada J, Mao JH, Hsu J, Jacks T, Balmain A
A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.
Nature genetics, Aug-2006;38(8):926-30.  Epub 2006 Jul 02.
Zhou BB, Peyton M, He B, Liu C, Girard L, Caudler E, Lo Y, Baribaud F, Mikami I, Reguart N, Yang G, Li Y, Yao W, Vaddi K, Gazdar AF, Friedman SM, Jablons DM, Newton RC, Fridman JS, Minna JD, Scherle PA
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Cancer cell, Jul-2006;10(1):39-50.
To MD, Gokgoz N, Doyle TG, Donoviel DB, Knight JA, Hyslop PS, Bernstein A, Andrulis IL
Functional characterization of novel presenilin-2 variants identified in human breast cancers.
Oncogene, Jun-15-2006;25(25):3557-64.  Epub 2006 Feb 13.
Raz DJ, He B, Rosell R, Jablons DM
Current concepts in bronchioloalveolar carcinoma biology.
Clinical cancer research : an official journal of the American Association for Cancer Research, Jun-15-2006;12(12):3698-704.
Raz DJ, Jablons DM
Bronchioloalveolar carcinoma is not associated with younger age at diagnosis: an analysis of the SEER database.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, May-2006;1(4):339-43.
Batra S, Shi Y, Kuchenbecker KM, He B, Reguart N, Mikami I, You L, Xu Z, Lin YC, Clément G, Jablons DM
Wnt inhibitory factor-1, a Wnt antagonist, is silenced by promoter hypermethylation in malignant pleural mesothelioma.
Biochemical and biophysical research communications, Apr-21-2006;342(4):1228-32.  Epub 2006 Feb 24.
Lin YC, You L, Xu Z, He B, Mikami I, Thung E, Chou J, Kuchenbecker K, Kim J, Raz D, Yang CT, Chen JK, Jablons DM
Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
Biochemical and biophysical research communications, Mar-10-2006;341(2):635-40.  Epub 2006 Jan 17.
Raz DJ, He B, Rosell R, Jablons DM
Bronchioloalveolar carcinoma: a review.
Clinical lung cancer, Mar-2006;7(5):313-22.
He B, Jablons DM
Wnt signaling in stem cells and lung cancer.
Ernst Schering Foundation symposium proceedings, 2006;(5)27-58.
You L, Kim J, He B, Xu Z, McCormick F, Jablons DM
Wnt-1 signal as a potential cancer therapeutic target.
Drug news & perspectives, 2006 Jan-Feb;19(1):27-31.
Kim KU, Wilson SM, Abayasiriwardana KS, Collins R, Fjellbirkeland L, Xu Z, Jablons DM, Nishimura SL, Broaddus VC
A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance.
American journal of respiratory cell and molecular biology, Dec-2005;33(6):541-8.  Epub 2005 Aug 25.
Reguart N, He B, Taron M, You L, Jablons DM, Rosell R
The role of Wnt signaling in cancer and stem cells.
Future oncology (London, England), Dec-2005;1(6):787-97.
Mazieres J, You L, He B, Xu Z, Twogood S, Lee AY, Reguart N, Batra S, Mikami I, Jablons DM
Wnt2 as a new therapeutic target in malignant pleural mesothelioma.
International journal of cancer, Nov-1-2005;117(2):326-32.
[    1  2  3  4  5  6  7  8  9  10  11     View All ]
X